Eye Manifestations
Eye Manifestations
Explore linked clinical trials. Standard reference: MESH:M000809214 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction | Chandler syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Endothelial Cell Loss, Corneal Endothelial Dystrophy 1, Eye Diseases, Hereditary, Eye Manifestations, Fuchs' endothelial dystrophy, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, congenital hereditary endothelial dystrophy of cornea, corneal disorder, corneal dystrophy, corneal edema, eye disorder, hereditary disease | Recruiting | Phase 2 | 2026-10-09 | NCT07729137 | |
| Effect of Acoltremon Ophthalmic Solution 0.003% on Tear Production and Symptoms in Patients With Tear Deficiency and Concurrent Neuropathic Corneal Pain | Eye Manifestations, Eye Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, dry eye syndrome, eye disorder, lacrimal apparatus disorder | Not yet recruiting | Phase 4 | 2026-10-06 | NCT07849803 | |
| Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP). | Eye Manifestations, Eye Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, eye disorder | Not yet recruiting | Phase 3 | 2026-09-29 | NCT07838506 | |
| A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery | Corneal Endothelial Cell Loss, Eye Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, corneal disorder, eye disorder | Recruiting | Phase 2 | 2026-08-06 | NCT07694375 | |
| Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy | Bell's palsy, DNA Virus Infections, Eye Manifestations, Herpesviridae infectious disease, Infections, Stomatognathic Diseases, cranial nerve neuropathy, eye disorder, eyelid disorder, facial nerve disorder, lagophthalmos, mouth disorder, nervous system disorder, paralytic lagophthalmos, viral infectious disease | Recruiting | Early phase 1 | 2026-06-02 | NCT06895902 | |
| A Clinical Study to Determine What Effect the EyeCool Treatment Has on the Eye's Surface Anatomy and Inflammation Response After Being Treated for Having Chronic Ocular Surface Pain (COSP) | Eye Manifestations, Eye Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, eye disorder | Recruiting | Not applicable | 2026-05-26 | NCT07059754 | |
| Self-Adhering Magnetic Device to Treat Corneal Exposure | Eye Manifestations, eye disorder, eyelid disorder, lagophthalmos, paralytic lagophthalmos | Recruiting | Not applicable | 2026-05-22 | NCT06291818 | |
| Phenotypic and Etiological Characterization of Susac Syndrome | Arterial Occlusive Diseases, Ear Diseases, Eye Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Susac syndrome, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, eye disorder, nervous system disorder, otorhinolaryngologic disease, retinal artery occlusion, retinal disorder, vascular disorder, vision disorder | Recruiting | Not stated | 2026-05-07 | NCT06881368 | |
| Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) | CNS demyelinating autoimmune disease, Eye Manifestations, Eye Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, nervous system disorder, optic nerve disorder, optic neuritis, vision disorder | Recruiting | Phase 2 | 2026-03-11 | NCT02521311 | |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers | Eye Manifestations, Eye Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, eye disorder | Active, not recruiting | Phase 1 | 2026-01-27 | NCT06978244 | |
| Safety and Tolerability of EO2002 | Corneal Endothelial Cell Loss, Eye Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, cataract, corneal disorder, eye disorder, lens disorder | Recruiting | Phase 1 | 2025-12-08 | NCT05587205 | |
| The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study | Corneal Endothelial Cell Loss, Eye Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, corneal disorder, eye disorder | Recruiting | Not stated | 2025-10-02 | NCT05847387 | |
| Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration | Eye Manifestations, Eye Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, eye disorder | Recruiting | Not applicable | 2025-09-19 | NCT07174739 | |
| Effect of Vitamin C Supplementation in Corneal Endothelial Damage in Phacoemulsification of Patients with Hard Cataracts | Corneal Endothelial Cell Loss, Eye Manifestations, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, cataract, corneal disorder, eye disorder, immune system disorder, immunoproliferative disorder, intraocular lymphoma, lens disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, ocular cancer | Recruiting | Not applicable | 2025-01-17 | NCT06781970 |